These signs commonly go away after a couple weeks of commencing the drug, but taking a reduced dose when you start treatment will help avert them completely. The efficacy of regime checking of serum calcitonin or thyroid ultrasound for early detection of medullary carcinoma in the thyroid in clients going through tirzepatide treatment is unsure.5